Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Failure in immune regulation begets IDDM in NOD mice.
Cameron MJ, Meagher C, Delovitch TL. Cameron MJ, et al. Among authors: delovitch tl. Diabetes Metab Rev. 1998 Jun;14(2):177-85. doi: 10.1002/(sici)1099-0895(199806)14:2<177::aid-dmr209>3.0.co;2-t. Diabetes Metab Rev. 1998. PMID: 9679670 Review.
CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
Mi QS, Meagher C, Delovitch TL. Mi QS, et al. Among authors: delovitch tl. Novartis Found Symp. 2003;252:146-60; discussion 160-4, 203-10. Novartis Found Symp. 2003. PMID: 14609217 Review.
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected].
Subramanian L, Blumenfeld H, Tohn R, Ly D, Aguilera C, Maricic I, Mansson JE, Buschard K, Kumar V, Delovitch TL. Subramanian L, et al. Among authors: delovitch tl. PLoS One. 2012;7(5):e37771. doi: 10.1371/journal.pone.0037771. Epub 2012 May 23. PLoS One. 2012. PMID: 22649557 Free PMC article.
Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.
Meagher C, Beilke J, Arreaza G, Mi QS, Chen W, Salojin K, Horst N, Cruikshank WW, Delovitch TL. Meagher C, et al. Among authors: delovitch tl. Diabetes. 2010 Nov;59(11):2862-71. doi: 10.2337/db09-0131. Epub 2010 Aug 6. Diabetes. 2010. PMID: 20693344 Free PMC article.
Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner.
Hussain S, Delovitch TL. Hussain S, et al. Among authors: delovitch tl. J Immunol. 2007 Dec 1;179(11):7225-32. doi: 10.4049/jimmunol.179.11.7225. J Immunol. 2007. PMID: 18025164 Free article.
CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses.
Meagher C, Arreaza G, Peters A, Strathdee CA, Gilbert PA, Mi QS, Santamaria P, Dekaban GA, Delovitch TL. Meagher C, et al. Among authors: delovitch tl. Diabetes. 2007 Mar;56(3):809-17. doi: 10.2337/db06-0619. Diabetes. 2007. PMID: 17327452
Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may not be a candidate gene of the diabetes susceptibility Idd4.1 locus.
Mi QS, Zhou L, Grattan M, Wang ZZ, Sivilotti M, She JX, Delovitch TL. Mi QS, et al. Among authors: delovitch tl. Ann N Y Acad Sci. 2006 Oct;1079:147-52. doi: 10.1196/annals.1375.022. Ann N Y Acad Sci. 2006. PMID: 17130546
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D, Mi QS, Hussain S, Delovitch TL. Ly D, et al. Among authors: delovitch tl. J Immunol. 2006 Sep 15;177(6):3695-704. doi: 10.4049/jimmunol.177.6.3695. J Immunol. 2006. PMID: 16951329
A defect in lineage fate decision during fetal thymic invariant NKT cell development may regulate susceptibility to type 1 diabetes.
Wagner MJ, Hussain S, Mehan M, Verdi JM, Delovitch TL. Wagner MJ, et al. Among authors: delovitch tl. J Immunol. 2005 Jun 1;174(11):6764-71. doi: 10.4049/jimmunol.174.11.6764. J Immunol. 2005. PMID: 15905517
Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.
Hussain S, Wagner M, Ly D, Delovitch TL. Hussain S, et al. Among authors: delovitch tl. Immunol Res. 2005;31(3):177-88. doi: 10.1385/IR:31:3:177. Immunol Res. 2005. PMID: 15888910 Review.
135 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback